|Bid||239.26 x 1000|
|Ask||259.85 x 800|
|Day's Range||240.79 - 244.08|
|52 Week Range||146.09 - 256.22|
|PE Ratio (TTM)||69.97|
|Earnings Date||Nov 1, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||264.80|
Big tech stocks are weighing on the Nasdaq-100, dropping the market-leading index to a three-week low. Trade tensions and a tariff list chock-full of the industry's profitable products suggest even lower prices before the sector resumes its bullish trajectory. Keepers of the Nasdaq-100 have broadened its scope in recent years, adding non-tech blue chips that include American Airlines Group Inc. ( AAL) and Walgreen Boots Alliance, Inc. ( WBA).
IDEXX (IDXX) continues to see strong organic growth, driven by solid sales at the CAG business. However, unfavorable currency movement remains a concern.
WESTBROOK, Maine, Sept. 10, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), the global leader in rapid microbiological testing for water, today announced that the IDEXX Pseudalert® method has been published as the International Organization for Standardization (ISO) worldwide standard 16266-2 for the 24-hour detection of Pseudomonas aeruginosa in water. P. aeruginosa can cause life-threatening infections in hospitals and is a frequent cause of skin, ear, and eye infections from pool and spa water. ISO is a global, widely recognized organization focused on ensuring that products and services are safe, reliable, and of good quality.
Amid the trade tensions between the United States and China, investors continued to pour money into fast-growing companies, pushing the Nasdaq Composite Index to new highs for the second consecutive day. The benchmark crossed the 8,000 milestone for the first time and is now up 16.1% this year so far.
Chairman, President & CEO of Idexx Laboratories Inc (NASDAQ:IDXX) Jonathan W Ayers sold 30,000 shares of IDXX on 08/23/2018 at an average price of $245.5 a share.
Amazon could soon join IBD 50 stocks Planet Fitness, Idexx Laboratories and Atlassian in forming a rare bullish chart pattern: the ascending base.
A strong year so far has left animal health specialist Idexx atop a very special base pattern, just as analysts project a big Q3 earnings gain.
WESTBROOK, Maine, Aug. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that its U.S. reference laboratory division will significantly expand its rapid overnight service, known as IDEXX-Direct® service, for thousands of rural U.S. veterinary practices. Through a new, state-of-the-art reference laboratory in Louisville, Kentucky, IDEXX will provide thousands of veterinary hospitals across the country with additional flexibility by offering the latest possible patient sample pick-up time with next morning results. Veterinarians often see patients right until a practice closes for the day.
The $1.3 billion Oppenheimer Discovery Mid Cap Growth Fund is outperforming this year. It's doing that with stock diversification.
last week and took a cautious approach to the price action. Last night Jim Cramer in his "Executive Decision" segment sat down with Jonathan Ayers, chairman, CEO and president of IDEXX. The pet health company posted a six-cents-a-share earnings beat with a 14% rise in revenues and raised forecasts.
WESTBROOK, Maine , Aug. 6, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host ...
In the second quarter of 2018, Merck’s (MRK) Animal Health business generated revenues of $1.1 billion compared to $955.0 million in the second quarter of 2017, reflecting ~14% growth on a year-over-year (or YoY) basis and 2% growth sequentially. In the second quarter of 2018, in the US market and international markets (outside the U.S. markets), Merck’s Animal Health business generated revenues of $311.0 million and $779.0 million, respectively, reflecting ~15% and ~14% YoY growth.
NEW YORK, Aug. 06, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of A10 ...
This is the kind of out-performance we would all like to have in our portfolios and be able to impress our friends at cocktail parties. In this daily bar chart of IDXX, below, we can see a strong uptrend from January. The daily On-Balance-Volume (OBV) line shows a positive trend from November.
Jim Cramer hears from Idexx Laboratories Chairman and CEO Jonathan Ayers, who says preventative care is a key growth driver for his companion-animal-focused diagnostics company.